Modified Norwood operation for hypoplastic left heart syndrome

Area of Science:

• Pediatric Cardiology
• Cardiac Surgery
• Neonatal Intensive Care

Background:

• Hypoplastic left heart syndrome (HLHS) is a severe congenital heart defect requiring complex surgical intervention.
• The Norwood operation is a critical first-stage palliation for HLHS.
• Perioperative management strategies, including inhaled nitric oxide (iNO) and extracorporeal membrane oxygenation (ECMO), are crucial for improving outcomes.

Purpose of the Study:

• To evaluate the early results of the Norwood operation in infants with HLHS.
• To assess the impact of perioperative inhaled nitric oxide and extracorporeal membrane oxygenation on survival.
• To identify predictors of hospital mortality in this patient population.

Main Methods:

• Retrospective review of medical records for 50 infants undergoing a modified Norwood operation between April 1997 and March 2001.
• Ductal cannulation for cardiopulmonary bypass was used in all cases.
• Selective use of iNO for persistent hypoxia and ECMO for hemodynamic instability or inability to wean from bypass.

Main Results:

• The 30-day mortality rate was 22%, and the hospital mortality rate was 32%.
• ECMO was initiated in 16 infants, primarily for low cardiac output or difficulty separating from bypass.
• Renal failure requiring hemofiltration during ECMO and cardiopulmonary arrest in the ICU were significant predictors of mortality (p < 0.05).

Conclusions:

• Early ECMO for hemodynamic instability and selective iNO for hypoxia may enhance survival in HLHS patients post-Norwood operation.
• Identifying and managing predictors of mortality, such as renal failure and cardiopulmonary arrest, is essential.
• This study highlights the importance of advanced supportive therapies in managing complex neonatal cardiac conditions.